Replies to post #61147 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Yes, it could be, but the timing fits some plans Cognate laid out last summer that were related to post phase III trial commercialization. It further fits the pace we hear Sawston is at. Also, it fits phase II initiation plans. Finally it fits precommercialization timeline for L. I can't argue with your point the expansion might be something else, but I'm leaning DCVax.

(It looks to me, from various descriptions and posts that May is unit installation month in Sawston and Memphis, does anyone have any information on Fraunhofer and/or King's College?)

[Doc logic]

chinatown1980,

I remember reading a post regarding the Sawston building plan permit that described a use plan for harvesting stem cells from cadavers for use in building regenerative scaffolding platforms. This use appears to be for other Cognate operations than that correlated to NWBO but anything stem cell derived that is not described very specifically can not be completely ruled out as unrelated. Best wishes.

[Smokey21]

Well, the current 10Q confirms expansion in US as well as the UK under Results of Operations/Operating Costs:

"Additional substantial costs relate to the expansion of manufacturing facilities and capacity, in both the US and Europe."